Skip to main content
Evidence Based Longevity (EBL)Check what I take
Evidence Trace, complete trial record
In plain terms

In plain terms: Inspiratory Muscle Training has some human trial evidence supporting it, but the evidence is not yet strong enough for EBL to call it established. It is worth knowing about and worth discussing with your clinician.

Inspiratory Muscle Training

B Supported: a good trial, backed by more
Category Devices
Evidence RCT + meta-analysis of randomized trials
Reviewed October 2026
PMIDs 34184544 · 37803506 · 36107991 · 36576599 · 41721779 · 27091540 · 32730174 · 21985749 · 29604403 · 37258418
The endpoint this grade is based on: Surrogate biomarker endpoint

The evidence as the record states it

Craighead et al. (Journal of the American Heart Association, 2021; PMID 34184544): double-blind, sham-controlled trial, 36 completers aged 50 to 79 with systolic pressure at or above 120 mmHg, 30 breaths a day at about 75% of maximal inspiratory pressure for 6 weeks; casual systolic pressure fell from 135 to 126 mmHg with training and did not change with sham, and 24-hour systolic pressure was lower than sham. Li et al. (Journal of Clinical Hypertension, 2023; PMID 37803506): 12 articles, 386 participants, systolic -7.93 mmHg and diastolic -3.80 mmHg. Craighead et al. (Journal of Applied Physiology, 2022; PMID 36107991): five sham-controlled pilot trials pooled, systolic -9 mmHg with training and no change with sham. Chen et al. (Sleep and Breathing, 2023; PMID 36576599): 7 trials, 160 patients with sleep apnea, systolic -10.77 mmHg, low certainty, apnea-hypopnea index unchanged. Zuo et al. (Annals of the American Thoracic Society, 2026; PMID 41721779): 10 trials in sleep apnea, systolic -6.63 mmHg, no improvement in apnea-hypopnea index. Silva de Sousa et al. (Journal of Sleep Research, 2024; PMID 37258418): 13 trials at high risk of bias, training may not beat sham on the apnea-hypopnea index. Smaller trials: Vranish et al. (Sleep, 2016; PMID 27091540), single-blind, 24 adults with sleep apnea, systolic 12.3 mmHg lower than sham; Ramos-Barrera et al. (J Appl Physiol, 2020; PMID 32730174), 25 older adults with sleep apnea, systolic fell 8.8 mmHg within the training group while the low-resistance control did not change; Ferreira et al. (Int J Cardiol, 2013; PMID 21985749), 13 hypertensive patients, 24-hour systolic fell from 133.2 to 125.2 mmHg within the training group, no between-group comparison reported; Ublosakka-Jones et al. (Exp Gerontol, 2018; PMID 29604403), 32 older adults with treated systolic hypertension, home systolic fell 20 mmHg with slow loaded breathing against 5 mmHg with deep breathing.

PMID 34184544 PMID 37803506 PMID 36107991 PMID 36576599 PMID 41721779 PMID 27091540 PMID 32730174 PMID 21985749 PMID 29604403 PMID 37258418

Evidence by specific use

Resting systolic blood pressure, high-resistance inspiratory muscle strength training
Grade B
Craighead et al. (J Am Heart Assoc, 2021; PMID 34184544), double-blind and sham-controlled, supported by Li et al. (J Clin Hypertens, 2023; PMID 37803506) and Craighead et al. (J Appl Physiol, 2022; PMID 36107991). Blood pressure is a surrogate, which caps the letter at B.
PMID 34184544 PMID 37803506 PMID 36107991 PMID 36576599 PMID 41721779 PMID 27091540 PMID 32730174 PMID 21985749 PMID 29604403
PMID 34184544 PMID 37803506 PMID 36107991 PMID 36576599 PMID 41721779 PMID 27091540 PMID 32730174 PMID 21985749 PMID 29604403
Sleep apnea severity (apnea-hypopnea index)
Grade D
Zuo et al. (Ann Am Thorac Soc, 2026; PMID 41721779), Chen et al. (Sleep Breath, 2023; PMID 36576599) and Silva de Sousa et al. (J Sleep Res, 2024; PMID 37258418) found no improvement in the apnea-hypopnea index. Tested and no benefit: D on Route 2.
PMID 41721779 PMID 36576599 PMID 37258418
PMID 41721779 PMID 36576599 PMID 37258418

Why Grade B and not Grade A

Grade B reflects moderate human evidence -- typically a single strong trial, multiple smaller trials, or surrogate endpoint data without hard clinical outcome replication. To reach Grade A, Inspiratory Muscle Training would require at least one additional independent randomized trial demonstrating a hard clinical endpoint or objectively measured functional outcome in a comparable population.

What this grade covers and what it does not

Grade B on resting systolic blood pressure in midlife and older adults with above-normal pressure or sleep apnea. A sham-controlled trial (Craighead et al., 2021; PMID 34184544) is supported by pooled analyses (Li et al., 2023; PMID 37803506; Craighead et al., 2022; PMID 36107991; Chen et al., 2023; PMID 36576599; Zuo et al., 2026; PMID 41721779). The Arizona and Colorado groups share a funding grant, so their trials are collaborators rather than fully independent; the Brazilian and Thai trials are independent and small. Blood pressure is a surrogate, which caps the letter at B. WHAT THIS GRADE DOES NOT COVER: sleep apnea severity, where pooled trials found no benefit and the use is graded D; replacement of primary apnea treatment; clinical cardiovascular events; and adults with systolic pressure below 120.

What would move this grade

An independent randomized trial demonstrating a hard clinical endpoint -- mortality, major adverse event, or objectively confirmed functional improvement -- in an adequately powered sample, with results independently replicated, would support Grade A.

How to track whether this is working Maximal inspiratory pressure (PImax) at baseline and every 4 weeks: this is the direct measure of the training effect. Resting systolic blood pressure at baseline and 6 weeks; Craighead et al. (PMID 34184544) reported a systolic reduction of about 9 mmHg with high-resistance inspiratory muscle strength training at 30 breaths/day over six weeks. Also monitor VO2max and submaximal exercise tolerance at 8 weeks.